## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-05-20T11:46:53.745Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Rash ID: Skin Rash Identifier" developer_entity: "Appsmiths LLC" bundle_id: "bsmith.rash" app_store_id: "1488063716" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-03-02" report_date: "2026-05-20" last_verified: "2026-05-20" report_version: "4.5.0" total_reviews: 355 overall_rating: 4.42 sentiment: "Upset" sentiment_score: 20 confidence: "low" confidence_score: 0.8 top_praise_theme: "Accurate identification of skin conditions provides medical value for some users" top_complaint_theme: "Subscription paywalls appearing before any functional scan results are provided" top_request_theme: "Alternative monetization models that charge per result rather than recurring subscriptions" review_sample_size: 74 total_review_count: 74 analyzed_review_count: 65 data_age_days: 0 momentum_velocity: "maintenance" intelligence_version: 3 competitor_count: 2 tags: ["medical", "subscription", "upset sentiment", "mobile app", "app review", "app analysis", "individuals", "seeking", "immediate,"] canonical_url: "https://marlvel.ai/intel-report/medical/bsmith-rash" license: "CC-BY-NC 4.0" content_version: "v2" --- # Rash ID: Skin Rash Identifier App Audit ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 4.42 · Sentiment Upset - **Recent focus**: Subscription paywalls appearing before any functional scan results are provided (top complaint) · Accurate identification of skin conditions provides medical value for some users (top praise) · Alternative monetization models that charge per result rather than recurring subscriptions (top request) > **TL;DR:** Rash ID: Skin Rash Identifier is a medical app by Appsmiths LLC, rated 4.42/5 by 355 users, with Upset user sentiment (20/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** Rash ID: Skin Rash Identifier faces Upset user sentiment (4.42/5 from 355 reviews), with subscription paywalls appearing before any functional scan results are provided as the primary user concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.42/5 (355 reviews) | | **User Mood** | Upset | | **Category** | Medical | | **Developer** | Appsmiths LLC | | **Pricing** | Subscription | | **Platforms** | iOS & Android | | **Confidence** | Low (0.8/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** Appsmiths LLC - **Category:** Medical - **Target Audience:** Individuals seeking immediate, preliminary information about skin concerns or rashes to inform their next steps before consulting a healthcare professional. - **Platforms:** iOS & Android - **Version Audited:** 4.5.0 - **Audit Date:** 2026-05-20 - **Signal Count:** 74 reviews analyzed - **Confidence:** Low (0.8/1.0) - **App Store ID (iOS):** 1488063716 - **Bundle ID:** bsmith.rash - **Google Play ID:** bsmith.rash - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-05-20 - **Short Description:** Your AI rash identifier & skin analysis tool. Get instant clarity. Scan Today. ## Executive Snapshot **What it is:** Rash ID is an AI-powered skin analysis tool for iOS and Android that combines image scanning with symptom reporting to identify dermatological conditions. **Why users hire it:** Users hire the app to gain immediate, preliminary clarity on skin concerns, reducing the uncertainty of self-diagnosis before seeking professional medical advice. ## App DNA (Features & Intent) - **[Differentiator] Dual-Input AI Analysis:** Combines image recognition with user-provided symptom descriptions. * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] MUM AI Dermatologist Chat:** Conversational assistant that asks targeted questions and explains reasoning. * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior. - **[Standard] Scan History & Progress Tracking:** Saves images and logs to monitor skin changes. * *User Intent:* Users seek enhanced value through premium features. ## Market Position {#market-position} Rash ID occupies a niche in the Medical category, but its grossing rank volatility across international markets (e.g., #30 in AE, #21 in IE) suggests an unstable revenue base. The high frequency of technical complaints relative to its 4.45 average rating indicates that current growth is driven by curiosity rather than long-term utility. ## Monetization Strategy - **Model:** Subscription - **Tiers:** Free tier: one initial Quick Scan, Premium subscription: unlimited Quick Scans and MUM AI chat - **Analysis:** The freemium model uses a single free-scan trial to demonstrate utility before gating the advanced conversational AI behind a subscription. ## 🔴 User Sentiment (Low Confidence: 65 of 74 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.42/5 - **Platform Split:** iOS 4.6/5 (134 ratings) | Android 4.3/5 (221 ratings) - **Overall Sentiment:** Upset - **Note:** The 4.42/5 store rating reflects cumulative history, while the Upset sentiment reflects recent user reviews analyzed by our AI pipeline. ### Top Praises - **Accurate identification of skin conditions provides medical value for some users** ### Top Complaints (Impact Areas) - **Subscription paywalls appearing before any functional scan results are provided** - **Technical failures during the scanning process prevent any usable output** ### Top Requests (What Users Want) - **Alternative monetization models that charge per result rather than recurring subscriptions** ## SWOT Analysis {#swot} **Core Strengths:** - Dual-input analysis mechanism differentiates from static image-only scanners - Secure, HIPAA-compliant data processing builds user trust **Critical Frictions:** - Subscription paywall blocks functional utility for new users - High frequency of scan failures erodes core value - Inconsistent diagnostic results across repeated attempts **Growth Levers:** - Implement pay-per-use model for infrequent users - Expand library to include more chronic condition tracking **Market Threats:** - VisualDx clinical standard undermines consumer-facing credibility - Eka's high-velocity development cycle outpaces current update cadence ## Recent Changes (v2 → v3) {#recent-changes} The app introduced new engagement features like scan history and routines, but core diagnostic utility remains hampered by technical scan failures and a restrictive subscription-first monetization model. **Overall trend**: Declining **Compared at**: 2026-05-20 ### High-impact changes - **[Shifted] Subscription-first gating** (pricing) — Monetization model shifted to gate core AI chat behind a subscription before providing any functional scan results. ### Medium-impact changes - **[Added] Scan History and Routines** (features) — Added offline scan history and personalized skincare routines, expanding the app beyond a single-scan utility. - **[Declined] Rating and Sentiment** (sentiment) — Rating declined from 4.6 to 4.45, with user complaints shifting toward paywalls appearing before functional output. - **[Added] New Competitive Threats** (swot) — Added VisualDx and Eka as specific competitive threats, highlighting gaps in clinical image libraries and development velocity. ## What's New - **Latest (v4.5.0, 2 months ago):** Added offline auto-save for scan history and introduced personalized skincare routines with follow-up reminders. ## App Momentum (Maintenance) {#momentum} - Rebuilt scan history for offline sync. - Redesigned camera interface for focus. - Refreshed onboarding flow. > **Cadence:** 2 total versions · 2 majors in last 6 months · 78 days since last update · 2 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} Rash ID: Skin Rash Identifier is a challenged medical app that is available. With a 4.42/5 rating from 355 reviews, it faces significant user friction. > **Bottom Line:** Rash ID provides a unique dual-input diagnostic tool, but the aggressive paywall and technical instability alienate the user base, so the team must prioritize scan reliability and a more flexible monetization model to prevent further churn. **Best for:** Individuals seeking immediate, preliminary information about skin concerns or rashes to inform their next steps before consulting a healthcare professional. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] [HIGH IMPACT] Pivot monetization to pay-per-use because subscription paywalls trigger high churn → increase conversion rate — *Subscription paywalls are the #1 complaint theme in user sentiment data.* _(trade-off: deprioritize Pause the annual subscription discount test — pay-per-use has higher immediate revenue potential.)_ - [ ] [INVEST] [HIGH IMPACT] Audit camera initiation logic because scan failures are the #2 complaint theme → restore basic utility — *Technical failures during scanning prevent any usable output for the user.* _(trade-off: deprioritize Deprioritize the new skincare routine feature — stability is the current retention blocker.)_ ### Feature Gaps vs Competitors - Peer-reviewed clinical image library (available in VisualDx but absent here) - Broad health record management (available in Eka but absent here) ### Outlook: Declining The medical-AI market is consolidating around tools that provide verifiable clinical support, leaving Rash ID exposed due to its reliance on unverified consumer-facing diagnostics. Unless the team resolves the core scan failures and shifts to a more user-friendly monetization model, the app will continue to lose ground to more stable, multi-functional health platforms. - 🔴 Technical scan failures in the latest release prevent usable output, which compounds the rating drag already visible on Android. - 🔴 The subscription-first monetization model alienates new users, leading to high churn and negative sentiment regarding the app's transparency. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.42/5 | | Total Reviews | 355 | | Sentiment | Upset (20/100) | | Confidence | Low | | Pricing Model | Subscription | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Rash ID: Skin Rash Identifier** (this app) | 4.42/5 | Upset | Appsmiths LLC | | [VisualDx](https://marlvel.ai/intel-report/medical/com-logicalimages-visualdxmobile) | 4.4/5 | N/A | Logical Images | | [Eka: Health AI, ABHA, Records](https://marlvel.ai/intel-report/medical/com-orbi-eka-care) | 4.6/5 | N/A | Orbi Health private limited | | [Move On with AJ](https://marlvel.ai/intel-report/medical/move-on-with-aj) | 4.3/5 | Excited | Universal Relaxation Ltd | | [Ortho Traumapedia](https://marlvel.ai/intel-report/medical/orthotraumapedia) | 3.5/5 | N/A | HTG, LLC | | [NYC Employees PPO Plan](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) | 4.6/5 | N/A | United HealthCare Services, Inc. | ## Company Profile - **Developer:** Appsmiths LLC - **Website:** [https://www.rash-id.com](https://www.rash-id.com) - **Social:** [Instagram](https://www.instagram.com/rashid_app) · [Facebook](https://www.facebook.com/rashidentifier) · [TikTok](https://www.tiktok.com/@rashid_app) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/rash-id-skin-rash-identifier/id1488063716?uo=2) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=bsmith.rash&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.rash-id.com) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*VisualDx*](https://marlvel.ai/intel-report/medical/com-logicalimages-visualdxmobile) (Logical Images) — 4.4/5 Rating | N/A Sentiment - [*Eka: Health AI, ABHA, Records*](https://marlvel.ai/intel-report/medical/com-orbi-eka-care) (Orbi Health private limited) — 4.6/5 Rating | N/A Sentiment - [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment - [*Ortho Traumapedia*](https://marlvel.ai/intel-report/medical/orthotraumapedia) (HTG, LLC) — 3.5/5 Rating | N/A Sentiment - [*NYC Employees PPO Plan*](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment - [*DeepScribe*](https://marlvel.ai/intel-report/medical/deepscribe) (DeepScribe) — 4.0/5 Rating | N/A Sentiment - [*Procedure Log*](https://marlvel.ai/intel-report/medical/com-rmk-iosapps-procedure-log) (Robert Kuhnhenn) — 4.8/5 Rating | N/A Sentiment - [*Dario Health*](https://marlvel.ai/intel-report/medical/dario-health) (LabStyle Innovation Ltd) — 4.8/5 Rating | Negative Sentiment - [*Access - by McGraw Hill*](https://marlvel.ai/intel-report/medical/access-by-mcgraw-hill) (McGraw-Hill) — 3.9/5 Rating | N/A Sentiment - [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.8/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 74 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/bsmith-rash) Data licensed for AI Agent attribution under CC-BY-NC 4.0.